BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Böttner M, Zorenkov D, Hellwig I, Barrenschee M, Harde J, Fricke T, Deuschl G, Egberts JH, Becker T, Fritscher-Ravens A. Expression pattern and localization of alpha-synuclein in the human enteric nervous system. Neurobiol Dis. 2012;48:474-480. [PMID: 22850485 DOI: 10.1016/j.nbd.2012.07.018] [Cited by in Crossref: 83] [Cited by in F6Publishing: 79] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Jellinger KA. Potential clinical utility of multiple system atrophy biomarkers. Expert Review of Neurotherapeutics 2017;17:1189-208. [DOI: 10.1080/14737175.2017.1392239] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
2 Visanji NP, Mollenhauer B, Beach TG, Adler CH, Coffey CS, Kopil CM, Dave KD, Foroud T, Chahine L, Jennings D; the Systemic Synuclein Sampling Study (S4). The Systemic Synuclein Sampling Study: toward a biomarker for Parkinson's disease. Biomarkers in Medicine 2017;11:359-68. [DOI: 10.2217/bmm-2016-0366] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
3 Mahlknecht P, Seppi K, Poewe W. The Concept of Prodromal Parkinson's Disease. J Parkinsons Dis. 2015;5:681-697. [PMID: 26485429 DOI: 10.3233/jpd-150685] [Cited by in Crossref: 108] [Cited by in F6Publishing: 59] [Article Influence: 18.0] [Reference Citation Analysis]
4 Borghammer P. How does parkinson's disease begin? Perspectives on neuroanatomical pathways, prions, and histology. Mov Disord 2018;33:48-57. [PMID: 28843014 DOI: 10.1002/mds.27138] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 13.0] [Reference Citation Analysis]
5 Wang L, Zhao Z, Zhao L, Zhao Y, Yang G, Wang C, Gao L, Niu C, Li S. Lactobacillus plantarum DP189 Reduces α-SYN Aggravation in MPTP-Induced Parkinson’s Disease Mice via Regulating Oxidative Damage, Inflammation, and Gut Microbiota Disorder. J Agric Food Chem . [DOI: 10.1021/acs.jafc.1c07711] [Reference Citation Analysis]
6 Houser MC, Tansey MG. The gut-brain axis: is intestinal inflammation a silent driver of Parkinson's disease pathogenesis? NPJ Parkinsons Dis 2017;3:3. [PMID: 28649603 DOI: 10.1038/s41531-016-0002-0] [Cited by in Crossref: 199] [Cited by in F6Publishing: 188] [Article Influence: 39.8] [Reference Citation Analysis]
7 Venkatesan D, Iyer M, Narayanasamy A, Siva K, Vellingiri B. Kynurenine pathway in Parkinson's disease-An update. eNeurologicalSci 2020;21:100270. [PMID: 33134567 DOI: 10.1016/j.ensci.2020.100270] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
8 Borghammer P, Horsager J, Andersen K, Van Den Berge N, Raunio A, Murayama S, Parkkinen L, Myllykangas L. Neuropathological evidence of body-first vs. brain-first Lewy body disease. Neurobiol Dis 2021;161:105557. [PMID: 34763110 DOI: 10.1016/j.nbd.2021.105557] [Reference Citation Analysis]
9 Schneider SA, Boettner M, Alexoudi A, Zorenkov D, Deuschl G, Wedel T. Can we use peripheral tissue biopsies to diagnose Parkinson's disease? A review of the literature. Eur J Neurol 2016;23:247-61. [PMID: 26100920 DOI: 10.1111/ene.12753] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 9.0] [Reference Citation Analysis]
10 Urban P, Falkenburger B, Jost WH, Ransmayr G, Riederer P, Winkler C. [Structure and efferences of the substantia nigra pars compacta in Parkinson's disease]. Fortschr Neurol Psychiatr 2020;88:591-9. [PMID: 32396943 DOI: 10.1055/a-1149-9280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Gundersen V. Parkinson's Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy? Front Neurosci 2020;14:580311. [PMID: 33716638 DOI: 10.3389/fnins.2020.580311] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Corbillé AG, Preterre C, Rolli-Derkinderen M, Coron E, Neunlist M, Lebouvier T, Derkinderen P. Biochemical analysis of α-synuclein extracted from control and Parkinson's disease colonic biopsies. Neurosci Lett 2017;641:81-6. [PMID: 28126589 DOI: 10.1016/j.neulet.2017.01.050] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
13 Weyer-Menkhoff I, Pinter A, Schlierbach H, Schänzer A, Lötsch J. Epidermal expression of human TRPM8, but not of TRPA1 ion channels, is associated with sensory responses to local skin cooling. Pain 2019;160:2699-709. [PMID: 31343541 DOI: 10.1097/j.pain.0000000000001660] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
14 Araki K, Yagi N, Ikemoto Y, Yagi H, Choong CJ, Hayakawa H, Beck G, Sumi H, Fujimura H, Moriwaki T, Nagai Y, Goto Y, Mochizuki H. Synchrotron FTIR micro-spectroscopy for structural analysis of Lewy bodies in the brain of Parkinson's disease patients. Sci Rep 2015;5:17625. [PMID: 26621077 DOI: 10.1038/srep17625] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 7.3] [Reference Citation Analysis]
15 Bu LL, Huang KX, Zheng DZ, Lin DY, Chen Y, Jing XN, Liang YR, Tao EX. Alpha-Synuclein Accumulation and Its Phosphorylation in the Enteric Nervous System of Patients Without Neurodegeneration: An Explorative Study. Front Aging Neurosci 2020;12:575481. [PMID: 33328957 DOI: 10.3389/fnagi.2020.575481] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Swaminathan M, Fung C, Finkelstein DI, Bornstein JC, Foong JPP. α-Synuclein Regulates Development and Function of Cholinergic Enteric Neurons in the Mouse Colon. Neuroscience 2019;423:76-85. [PMID: 31705886 DOI: 10.1016/j.neuroscience.2019.10.029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Wang XT, Liu FT, Bi YL, Shen XN, Xu W, Wang J, Tan L, Yu JT. Associations of sleep characteristics with alpha-synuclein in cerebrospinal fluid in older adults. Ann Clin Transl Neurol 2020;7:2026-34. [PMID: 32949229 DOI: 10.1002/acn3.51204] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Schaeffer E, Kluge A, Böttner M, Zunke F, Cossais F, Berg D, Arnold P. Alpha Synuclein Connects the Gut-Brain Axis in Parkinson's Disease Patients - A View on Clinical Aspects, Cellular Pathology and Analytical Methodology. Front Cell Dev Biol 2020;8:573696. [PMID: 33015066 DOI: 10.3389/fcell.2020.573696] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
19 Hilton D, Stephens M, Kirk L, Edwards P, Potter R, Zajicek J, Broughton E, Hagan H, Carroll C. Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease. Acta Neuropathol 2014;127:235-41. [PMID: 24240814 DOI: 10.1007/s00401-013-1214-6] [Cited by in Crossref: 177] [Cited by in F6Publishing: 165] [Article Influence: 19.7] [Reference Citation Analysis]
20 Chung SJ, Kim J, Lee HJ, Ryu H, Kim K, Lee JH, Jung KW, Kim MJ, Kim M, Kim YJ, Yun S, Lee J, Hong S, Myung S. Alpha-synuclein in gastric and colonic mucosa in Parkinson's disease: Limited role as a biomarker: Enteric Alpha-Synuclein In Parkinson's Disease. Mov Disord 2016;31:241-9. [DOI: 10.1002/mds.26473] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 7.3] [Reference Citation Analysis]
21 Böttner M, Fricke T, Müller M, Barrenschee M, Deuschl G, Schneider SA, Egberts J, Becker T, Fritscher-ravens A, Ellrichmann M, Schulz-schaeffer WJ, Wedel T. Alpha-synuclein is associated with the synaptic vesicle apparatus in the human and rat enteric nervous system. Brain Research 2015;1614:51-9. [DOI: 10.1016/j.brainres.2015.04.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
22 Kuzkina A, Schulmeyer L, Monoranu C, Volkmann J, Sommer C, Doppler K. The aggregation state of α-synuclein deposits in dermal nerve fibers of patients with Parkinson's disease resembles that in the brain. Parkinsonism & Related Disorders 2019;64:66-72. [DOI: 10.1016/j.parkreldis.2019.03.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
23 Phillips RJ, Martin FN, Billingsley CN, Powley TL. Alpha-synuclein expression patterns in the colonic submucosal plexus of the aging Fischer 344 rat: implications for biopsies in aging and neurodegenerative disorders? Neurogastroenterol Motil 2013;25:e621-33. [PMID: 23809578 DOI: 10.1111/nmo.12176] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
24 Klingelhoefer L, Reichmann H. Parkinson’s disease as a multisystem disorder. J Neural Transm 2017;124:709-13. [DOI: 10.1007/s00702-017-1692-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
25 Mahlknecht P, Poewe W. Is there a need to redefine Parkinson’s disease? J Neural Transm 2013;120:9-17. [DOI: 10.1007/s00702-013-1038-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
26 Lee JM, Derkinderen P, Kordower JH, Freeman R, Munoz DG, Kremer T, Zago W, Hutten SJ, Adler CH, Serrano GE, Beach TG. The Search for a Peripheral Biopsy Indicator of α-Synuclein Pathology for Parkinson Disease. J Neuropathol Exp Neurol. [DOI: 10.1093/jnen/nlw103] [Cited by in Crossref: 18] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
27 Visanji NP, Marras C, Kern DS, Al Dakheel A, Gao A, Liu LW, Lang AE, Hazrati LN. Colonic mucosal a-synuclein lacks specificity as a biomarker for Parkinson disease. Neurology 2015;84:609-16. [PMID: 25589666 DOI: 10.1212/WNL.0000000000001240] [Cited by in Crossref: 102] [Cited by in F6Publishing: 40] [Article Influence: 14.6] [Reference Citation Analysis]
28 Kalia LV, Lang AE. Parkinson's disease. Lancet. 2015;386:896-912. [PMID: 25904081 DOI: 10.1016/s0140-6736(14)61393-3] [Cited by in Crossref: 2179] [Cited by in F6Publishing: 1084] [Article Influence: 311.3] [Reference Citation Analysis]
29 Sharrad DF, Chen BN, Gai WP, Vaikath N, El-agnaf OM, Brookes SJH. Rotenone and elevated extracellular potassium concentration induce cell-specific fibrillation of α-synuclein in axons of cholinergic enteric neurons in the guinea-pig ileum. Neurogastroenterol Motil 2017;29:e12985. [DOI: 10.1111/nmo.12985] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
30 Shin C, Yang H, Park S, Lee H, Kong S, Suh Y, Huh Y, Kim Y, Park S, Ahn T, Lee SH, Kim H, Jeon B. Prospective cohort study of patients with early gastric cancer to detect prodromal Parkinson disease (EGC-PPD): A study protocol and baseline characteristics. Journal of Clinical Neuroscience 2019;66:26-32. [DOI: 10.1016/j.jocn.2019.05.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
31 Visanji N, Marras C. The relevance of pre-motor symptoms in Parkinson’s disease. Expert Review of Neurotherapeutics 2015;15:1205-17. [DOI: 10.1586/14737175.2015.1083423] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
32 Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci 2017;18:435-50. [PMID: 28592904 DOI: 10.1038/nrn.2017.62] [Cited by in Crossref: 429] [Cited by in F6Publishing: 407] [Article Influence: 85.8] [Reference Citation Analysis]
33 Chiang HL, Lin CH. Altered Gut Microbiome and Intestinal Pathology in Parkinson's Disease. J Mov Disord 2019;12:67-83. [PMID: 31158941 DOI: 10.14802/jmd.18067] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
34 Travagli RA, Browning KN, Camilleri M. Parkinson disease and the gut: new insights into pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol 2020;17:673-85. [PMID: 32737460 DOI: 10.1038/s41575-020-0339-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 13.0] [Reference Citation Analysis]
35 Visanji NP, Marras C, Hazrati LN, Liu LW, Lang AE. Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker. Mov Disord 2014;29:444-50. [PMID: 24375496 DOI: 10.1002/mds.25789] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 6.6] [Reference Citation Analysis]
36 Boursi B, Mamtani R, Haynes K, Yang YX. Parkinson's disease and colorectal cancer risk-A nested case control study. Cancer Epidemiol 2016;43:9-14. [PMID: 27232063 DOI: 10.1016/j.canep.2016.05.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
37 Ambrosini YM, Borcherding D, Kanthasamy A, Kim HJ, Willette AA, Jergens A, Allenspach K, Mochel JP. The Gut-Brain Axis in Neurodegenerative Diseases and Relevance of the Canine Model: A Review. Front Aging Neurosci 2019;11:130. [PMID: 31275138 DOI: 10.3389/fnagi.2019.00130] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 10.0] [Reference Citation Analysis]
38 Santos SF, de Oliveira HL, Yamada ES, Neves BC, Pereira A Jr. The Gut and Parkinson's Disease-A Bidirectional Pathway. Front Neurol 2019;10:574. [PMID: 31214110 DOI: 10.3389/fneur.2019.00574] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 17.0] [Reference Citation Analysis]
39 Gold A, Turkalp ZT, Munoz DG. Enteric alpha-synuclein expression is increased in Parkinson's disease but not Alzheimer's disease. Mov Disord 2013;28:237-40. [PMID: 23362176 DOI: 10.1002/mds.25298] [Cited by in Crossref: 77] [Cited by in F6Publishing: 76] [Article Influence: 8.6] [Reference Citation Analysis]
40 Böttner M, Harde J, Barrenschee M, Hellwig I, Vogel I, Ebsen M, Wedel T. GDNF induces synaptic vesicle markers in enteric neurons. Neuroscience Research 2013;77:128-36. [DOI: 10.1016/j.neures.2013.08.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
41 Preterre C, Corbillé AG, Balloy G, Letournel F, Neunlist M, Derkinderen P. Optimizing Western Blots for the Detection of Endogenous α-Synuclein in the Enteric Nervous System. J Parkinsons Dis 2015;5:765-72. [PMID: 26599299 DOI: 10.3233/JPD-150670] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
42 Araki K, Yagi N, Nakatani R, Sekiguchi H, So M, Yagi H, Ohta N, Nagai Y, Goto Y, Mochizuki H. A small-angle X-ray scattering study of alpha-synuclein from human red blood cells. Sci Rep 2016;6:30473. [PMID: 27469540 DOI: 10.1038/srep30473] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
43 Rosenbaum C, Böttner M, Wedel T, Metzger M. Laser-Capture Microdissection for Layer-Specific Analysis of Enteric Ganglia. Methods Mol Biol 2018;1723:361-9. [PMID: 29344871 DOI: 10.1007/978-1-4939-7558-7_20] [Reference Citation Analysis]
44 Aldecoa I, Navarro-Otano J, Stefanova N, Sprenger FS, Seppi K, Poewe W, Cuatrecasas M, Valldeoriola F, Gelpi E, Tolosa E. Alpha-synuclein immunoreactivity patterns in the enteric nervous system. Neurosci Lett 2015;602:145-9. [PMID: 26163460 DOI: 10.1016/j.neulet.2015.07.005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
45 Ganguly U, Singh S, Pal S, Prasad S, Agrawal BK, Saini RV, Chakrabarti S. Alpha-Synuclein as a Biomarker of Parkinson's Disease: Good, but Not Good Enough. Front Aging Neurosci 2021;13:702639. [PMID: 34305577 DOI: 10.3389/fnagi.2021.702639] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Lee HJ, Jung KW, Chung SJ, Hong SM, Kim J, Lee JH, Hwang SW, Ryu HS, Kim MJ, Lee HS, Seo M, Park SH, Yang DH, Ye BD, Byeon JS, Choe J, Jung HY, Yang SK, Myung SJ. Relation of Enteric α-Synuclein to Gastrointestinal Dysfunction in Patients With Parkinson's Disease and in Neurologically Intact Subjects. J Neurogastroenterol Motil 2018;24:469-78. [PMID: 29969861 DOI: 10.5056/jnm17141] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
47 Gelpi E, Navarro-otano J, Tolosa E, Gaig C, Compta Y, Rey MJ, Martí MJ, Hernández I, Valldeoriola F, Reñé R, Ribalta T. Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders: Peripheral Alpha-Synuclein In Pd. Mov Disord 2014;29:1010-8. [DOI: 10.1002/mds.25776] [Cited by in Crossref: 196] [Cited by in F6Publishing: 186] [Article Influence: 24.5] [Reference Citation Analysis]
48 Moriarty GM, Janowska MK, Kang L, Baum J. Exploring the accessible conformations of N-terminal acetylated α-synuclein. FEBS Lett 2013;587:1128-38. [PMID: 23499431 DOI: 10.1016/j.febslet.2013.02.049] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
49 Braidy N, Gai WP, Xu YH, Sachdev P, Guillemin GJ, Jiang XM, Ballard JW, Horan MP, Fang ZM, Chong BH, Chan DK. Alpha-synuclein transmission and mitochondrial toxicity in primary human foetal enteric neurons in vitro. Neurotox Res 2014;25:170-82. [PMID: 24026637 DOI: 10.1007/s12640-013-9420-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
50 Barrenschee M, Zorenkov D, Böttner M, Lange C, Cossais F, Scharf AB, Deuschl G, Schneider SA, Ellrichmann M, Fritscher-Ravens A, Wedel T. Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease. Acta Neuropathol Commun 2017;5:1. [PMID: 28057070 DOI: 10.1186/s40478-016-0408-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 9.0] [Reference Citation Analysis]
51 Mulak A, Bonaz B. Brain-gut-microbiota axis in Parkinson's disease. World J Gastroenterol 2015; 21(37): 10609-10620 [PMID: 26457021 DOI: 10.3748/wjg.v21.i37.10609] [Cited by in CrossRef: 261] [Cited by in F6Publishing: 222] [Article Influence: 37.3] [Reference Citation Analysis]
52 Antunes L, Frasquilho S, Ostaszewski M, Weber J, Longhino L, Antony P, Baumuratov A, Buttini M, Shannon KM, Balling R, Diederich NJ. Similar α-Synuclein staining in the colon mucosa in patients with Parkinson's disease and controls. Mov Disord 2016;31:1567-70. [PMID: 27324838 DOI: 10.1002/mds.26702] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 6.6] [Reference Citation Analysis]
53 Brudek T. Inflammatory Bowel Diseases and Parkinson's Disease. J Parkinsons Dis 2019;9:S331-44. [PMID: 31609699 DOI: 10.3233/JPD-191729] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
54 Kline EM, Houser MC, Herrick MK, Seibler P, Klein C, West A, Tansey MG. Genetic and Environmental Factors in Parkinson's Disease Converge on Immune Function and Inflammation. Mov Disord 2021;36:25-36. [PMID: 33314312 DOI: 10.1002/mds.28411] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
55 Bougea A. Synuclein in neurodegeneration. Adv Clin Chem 2021;103:97-134. [PMID: 34229853 DOI: 10.1016/bs.acc.2020.08.007] [Reference Citation Analysis]
56 Rota L, Pellegrini C, Benvenuti L, Antonioli L, Fornai M, Blandizzi C, Cattaneo A, Colla E. Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a mouse model of alpha-synucleinopathy. Transl Neurodegener. 2019;8:5. [PMID: 30774946 DOI: 10.1186/s40035-019-0146-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
57 Orimo S, Ghebremedhin E, Gelpi E. Peripheral and central autonomic nervous system: does the sympathetic or parasympathetic nervous system bear the brunt of the pathology during the course of sporadic PD? Cell Tissue Res 2018;373:267-86. [PMID: 29869180 DOI: 10.1007/s00441-018-2851-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
58 Stokholm MG, Danielsen EH, Hamilton-dutoit SJ, Borghammer P. Pathological α-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients: α-Synuclein in Prodromal PD. Ann Neurol 2016;79:940-9. [DOI: 10.1002/ana.24648] [Cited by in Crossref: 170] [Cited by in F6Publishing: 159] [Article Influence: 28.3] [Reference Citation Analysis]
59 Gazerani P. Probiotics for Parkinson's Disease. Int J Mol Sci 2019;20:E4121. [PMID: 31450864 DOI: 10.3390/ijms20174121] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
60 Jellinger KA. Neuropathology of Nonmotor Symptoms of Parkinson's Disease. Int Rev Neurobiol 2017;133:13-62. [PMID: 28802920 DOI: 10.1016/bs.irn.2017.05.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
61 Shin C, Park S, Yun JY, Shin JH, Yang H, Lee H, Kong S, Suh Y, Shen G, Kim Y, Kim H, Jeon B. Fundamental limit of alpha-synuclein pathology in gastrointestinal biopsy as a pathologic biomarker of Parkinson’s disease: Comparison with surgical specimens. Parkinsonism & Related Disorders 2017;44:73-8. [DOI: 10.1016/j.parkreldis.2017.09.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
62 Liao JF, Cheng YF, You ST, Kuo WC, Huang CW, Chiou JJ, Hsu CC, Hsieh-Li HM, Wang S, Tsai YC. Lactobacillus plantarum PS128 alleviates neurodegenerative progression in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse models of Parkinson's disease. Brain Behav Immun 2020;90:26-46. [PMID: 32739365 DOI: 10.1016/j.bbi.2020.07.036] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
63 Ruffmann C, Bengoa-Vergniory N, Poggiolini I, Ritchie D, Hu MT, Alegre-Abarrategui J, Parkkinen L. Detection of alpha-synuclein conformational variants from gastro-intestinal biopsy tissue as a potential biomarker for Parkinson's disease. Neuropathol Appl Neurobiol 2018;44:722-36. [PMID: 29676021 DOI: 10.1111/nan.12486] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
64 Shultz JM, Resnikoff H, Bondarenko V, Joers V, Mejia A, Simmons H, Emborg ME. Neurotoxin-Induced Catecholaminergic Loss in the Colonic Myenteric Plexus of Rhesus Monkeys. J Alzheimers Dis Parkinsonism 2016;6:279. [PMID: 28090391 DOI: 10.4172/2161-0460.1000279] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
65 Behl T, Kaur I, Sehgal A, Singh S, Bhatia S, Al-Harrasi A, Zengin G, Bumbu AG, Andronie-Cioara FL, Nechifor AC, Gitea D, Bungau AF, Toma MM, Bungau SG. The Footprint of Kynurenine Pathway in Neurodegeneration: Janus-Faced Role in Parkinson's Disorder and Therapeutic Implications. Int J Mol Sci 2021;22:6737. [PMID: 34201647 DOI: 10.3390/ijms22136737] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Dogra N, Mani RJ, Katare DP. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease. Cell Mol Neurobiol 2021. [PMID: 33649989 DOI: 10.1007/s10571-021-01066-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
67 Kujawska M, Jodynis-Liebert J. What is the Evidence That Parkinson's Disease is a Prion Disorder, Which Originates in the Gut? Int J Mol Sci 2018;19:E3573. [PMID: 30424585 DOI: 10.3390/ijms19113573] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
68 Kelly LP, Carvey PM, Keshavarzian A, Shannon KM, Shaikh M, Bakay RA, Kordower JH. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease. Mov Disord. 2014;29:999-1009. [PMID: 24898698 DOI: 10.1002/mds.25736] [Cited by in Crossref: 115] [Cited by in F6Publishing: 110] [Article Influence: 12.8] [Reference Citation Analysis]
69 Villumsen M, Aznar S, Pakkenberg B, Jess T, Brudek T. Inflammatory bowel disease increases the risk of Parkinson’s disease: a Danish nationwide cohort study 1977–2014. Gut 2018;68:18-24. [DOI: 10.1136/gutjnl-2017-315666] [Cited by in Crossref: 102] [Cited by in F6Publishing: 95] [Article Influence: 25.5] [Reference Citation Analysis]
70 Visanji NP, Marras C, Liu LW, Hazrati LN, Lang AE. Reply to: Gray et al. Mov Disord 2014;29:1225-6. [PMID: 24925804 DOI: 10.1002/mds.25941] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Kim J, Park I, Park H, Kim S, Yun JA, Jung CK, Sung H, Lee J, Kang W. α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects. Neurol Sci 2017;38:171-9. [DOI: 10.1007/s10072-016-2745-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
72 Borghammer P. Is constipation in Parkinson's disease caused by gut or brain pathology? Parkinsonism & Related Disorders 2018;55:6-7. [DOI: 10.1016/j.parkreldis.2018.08.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
73 Kalampokini S, Becker A, Fassbender K, Lyros E, Unger MM. Nonpharmacological Modulation of Chronic Inflammation in Parkinson's Disease: Role of Diet Interventions. Parkinsons Dis 2019;2019:7535472. [PMID: 31534664 DOI: 10.1155/2019/7535472] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
74 Fasano A, Visanji NP, Liu LWC, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. The Lancet Neurology 2015;14:625-39. [DOI: 10.1016/s1474-4422(15)00007-1] [Cited by in Crossref: 349] [Cited by in F6Publishing: 163] [Article Influence: 49.9] [Reference Citation Analysis]
75 Ruffmann C, Parkkinen L. Gut Feelings About α-Synuclein in Gastrointestinal Biopsies: Biomarker in the Making? Mov Disord 2016;31:193-202. [PMID: 26799450 DOI: 10.1002/mds.26480] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 7.2] [Reference Citation Analysis]
76 Klingelhoefer L, Reichmann H. The Gut and Nonmotor Symptoms in Parkinson's Disease. Int Rev Neurobiol 2017;134:787-809. [PMID: 28805583 DOI: 10.1016/bs.irn.2017.05.027] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
77 Sprenger FS, Stefanova N, Gelpi E, Seppi K, Navarro-Otano J, Offner F, Vilas D, Valldeoriola F, Pont-Sunyer C, Aldecoa I, Gaig C, Gines A, Cuatrecasas M, Högl B, Frauscher B, Iranzo A, Wenning GK, Vogel W, Tolosa E, Poewe W. Enteric nervous system α-synuclein immunoreactivity in idiopathic REM sleep behavior disorder. Neurology 2015;85:1761-8. [PMID: 26475692 DOI: 10.1212/WNL.0000000000002126] [Cited by in Crossref: 89] [Cited by in F6Publishing: 29] [Article Influence: 12.7] [Reference Citation Analysis]
78 Corbillé AG, Neunlist M, Derkinderen P. Cross-linking for the analysis of α-synuclein in the enteric nervous system. J Neurochem 2016;139:839-47. [PMID: 27637918 DOI: 10.1111/jnc.13845] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
79 Derkinderen P, Rolli-Derkinderen M, Chapelet G, Neunlist M, Noble W. Tau in the gut, does it really matter? J Neurochem 2021;158:94-104. [PMID: 33569813 DOI: 10.1111/jnc.15320] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
80 Prigent A, Chapelet G, De Guilhem de Lataillade A, Oullier T, Durieu E, Bourreille A, Duchalais E, Hardonnière K, Neunlist M, Noble W, Kerdine-Römer S, Derkinderen P, Rolli-Derkinderen M. Tau accumulates in Crohn's disease gut. FASEB J 2020;34:9285-96. [PMID: 32436623 DOI: 10.1096/fj.202000414R] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
81 Barrenschee M, Böttner M, Harde J, Lange C, Cossais F, Ebsen M, Vogel I, Wedel T. SNAP-25 is abundantly expressed in enteric neuronal networks and upregulated by the neurotrophic factor GDNF. Histochem Cell Biol. 2015; Feb 6. [Epub ahead of print]. [PMID: 25655772 DOI: 10.1007/s00418-015-1310-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]